Watson RW - Search Results

1

Role of targeted therapy in the treatment of advanced prostate cancer.

Fizazi K, Sternberg CN, Fitzpatrick JM, Watson RW, Tabesh M. Fizazi K, et al. Among authors: watson rw. BJU Int. 2010 Mar;105(6):748-67. doi: 10.1111/j.1464-410X.2010.09236.x. BJU Int. 2010. PMID: 20353536 Review.

2

Epstein criteria for insignificant prostate cancer.

Oon SF, Watson RW, O'Leary JJ, Fitzpatrick JM. Oon SF, et al. Among authors: watson rw. BJU Int. 2011 Aug;108(4):518-25. doi: 10.1111/j.1464-410X.2011.09979.x. Epub 2011 Feb 14. BJU Int. 2011. PMID: 21320276 Review.

3

Target sites for manipulating apoptosis in prostate cancer.

Watson RW, Fitzpatrick JM. Watson RW, et al. BJU Int. 2000 Apr;85 Suppl 2:38-44. doi: 10.1046/j.1464-410x.2000.00057.x. BJU Int. 2000. PMID: 10781184 Review. No abstract available.

4

Signaling for the caspases: their role in prostate cell apoptosis.

Coffey RN, Watson RW, Fitzpatrick JM. Coffey RN, et al. Among authors: watson rw. J Urol. 2001 Jan;165(1):5-14. doi: 10.1097/00005392-200101000-00003. J Urol. 2001. PMID: 11125352 Review.

5

Insulin-like growth factor I and prostate cancer.

O'Brien MF, Watson RW, Fitzpatrick JM. O'Brien MF, et al. Among authors: watson rw. Urology. 2001 Jul;58(1):1-7. doi: 10.1016/s0090-4295(01)01004-4. Urology. 2001. PMID: 11445469 Review. No abstract available.

6

Heat-shock proteins inhibit induction of prostate cancer cell apoptosis.

Gibbons NB, Watson RW, Coffey RN, Brady HP, Fitzpatrick JM. Gibbons NB, et al. Among authors: watson rw. Prostate. 2000 Sep 15;45(1):58-65. doi: 10.1002/1097-0045(20000915)45:1<58::aid-pros7>3.0.co;2-#. Prostate. 2000. PMID: 10960843

7

The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validation.

Lundon DJ, Boland A, Prencipe M, Hurley G, O'Neill A, Kay E, Aherne ST, Doolan P, Madden SF, Clynes M, Morrissey C, Fitzpatrick JM, Watson RW. Lundon DJ, et al. Among authors: watson rw. BMC Cancer. 2017 Mar 1;17(1):163. doi: 10.1186/s12885-017-3100-4. BMC Cancer. 2017. PMID: 28249598 Free PMC article.

8

Detecting soluble clusterin in in-vitro and in-vivo models of prostate cancer.

Girard FP, Byrne J, Downes M, Fanning D, Desgrandchamps F, Fitzpatrick JM, Watson RW. Girard FP, et al. Among authors: watson rw. Neoplasma. 2010;57(5):488-93. doi: 10.4149/neo_2010_05_488. Neoplasma. 2010. PMID: 20568904

9

The identification and internal validation of a preoperative serum biomarker panel to determine extracapsular extension in patients with prostate cancer.

Oon SF, Fanning DM, Fan Y, Boyce S, Murphy TB, Fitzpatrick JM, Watson RW. Oon SF, et al. Among authors: watson rw. Prostate. 2012 Oct 1;72(14):1523-31. doi: 10.1002/pros.22506. Epub 2012 Mar 13. Prostate. 2012. PMID: 22415934

10

Priming prostate carcinoma cells for increased apoptosis is associated with up-regulation of the caspases.

Coffey RN, Watson RW, Hegarty PK, Watson CL, Wolohan L, Brady HR, O'Keane C, Fitzpatrick JM. Coffey RN, et al. Among authors: watson cl, watson rw. Cancer. 2001 Nov 1;92(9):2297-308. doi: 10.1002/1097-0142(20011101)92:9<2297::aid-cncr1576>3.0.co;2-b. Cancer. 2001. PMID: 11745284

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

236 results

Search Page